Experimental HIV vaccine successfully elicits broadly neutralizing antibodies to the virus

An experimental HIV vaccine developed by scientists at Scripps Research and the nonprofit vaccine research organization IAVI has reached an important milestone by eliciting antibodies that can neutralize a wide variety of HIV strains.